P.A.W. Capital Corp increased its stake in DocGo Inc. (NASDAQ:DCGO – Free Report) by 1.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,630,000 shares of the company’s stock after buying an additional 30,000 shares during the period. DocGo accounts for about 12.2% of P.A.W. Capital Corp’s portfolio, making the stock its 2nd largest position. P.A.W. Capital Corp owned 1.60% of DocGo worth $5,412,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently added to or reduced their stakes in the stock. nVerses Capital LLC increased its position in DocGo by 151.5% during the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after purchasing an additional 5,000 shares during the period. Gladius Capital Management LP purchased a new position in DocGo during the 2nd quarter valued at about $34,000. Nisa Investment Advisors LLC increased its position in DocGo by 693.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock valued at $37,000 after purchasing an additional 10,565 shares during the period. SG Americas Securities LLC purchased a new position in DocGo during the 2nd quarter valued at about $60,000. Finally, Victory Capital Management Inc. increased its position in DocGo by 124.0% during the 2nd quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after purchasing an additional 14,191 shares during the period. Hedge funds and other institutional investors own 56.44% of the company’s stock.
DocGo Trading Up 3.4 %
Shares of NASDAQ DCGO opened at $3.63 on Friday. DocGo Inc. has a 12 month low of $2.75 and a 12 month high of $6.90. The company has a 50 day simple moving average of $3.46 and a two-hundred day simple moving average of $3.32. The stock has a market cap of $371.42 million, a price-to-earnings ratio of 12.96, a PEG ratio of 2.95 and a beta of 0.91.
Analysts Set New Price Targets
A number of analysts have recently weighed in on DCGO shares. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 price target on shares of DocGo in a report on Friday, September 20th. Needham & Company LLC restated a “buy” rating and issued a $7.00 price target on shares of DocGo in a report on Thursday, August 8th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, DocGo currently has an average rating of “Buy” and an average target price of $6.10.
Read Our Latest Report on DocGo
DocGo Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
- Five stocks we like better than DocGo
- The 3 Best Fintech Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
- Market Cap Calculator: How to Calculate Market Cap
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Stock Dividend Cuts Happen Are You Ready?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.